Refrances
1. Goodgame RW, Genta RM, White AC, Chappell CL. Intensity of infection in AIDS-associated cryptosporidiosis. The Journal of infectious diseases. 1993;167(3):704-9.
2. Kotler DP. Gastrointestinal manifestations of human immunodeficiency virus infection. Advances in internal medicine. 1995;40:197-242.
3. Xiao L. Molecular epidemiology of cryptosporidiosis: an update. Experimental parasitology. 2010;124(1):80-9.
4. Goodgame RW, Genta RM, White AC, Chappell CL. Intensity of Infection in AIDS-Associated Cryptosporidiosis. The Journal of Infectious Diseases. 1993;167(3):704-9.
5. Tzipori S, Ward H. Cryptosporidiosis: biology, pathogenesis and disease. Microbes and infection. 2002;4(10):1047-58.
6. Chen XM, Keithly JS, Paya CV, LaRusso NF. Cryptosporidiosis. The New England journal of medicine. 2002;346(22):1723-31.
7. Kotler DP. Gastrointestinal manifestations of human immunodeficiency virus infections. Adv Int Med. 1995;40:197-242.
8. Miao YM, Awad-El-Kariem FM, Franzen C, Ellis DS, Müller A, Counihan HM, et al. Eradication of cryptosporidia and microsporidia following successful antiretroviral therapy. Journal of acquired immune deficiency syndromes (1999). 2000;25(2):124-9.
9. Maggi P, Larocca AM, Quarto M, Serio G, Brandonisio O, Angarano G, et al. Effect of antiretroviral therapy on cryptosporidiosis and microsporidiosis in patients infected with human immunodeficiency virus type 1. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology. 2000;19(3):213-7.
10. Manabe YC, Clark DP, Moore RD, Lumadue JA, Dahlman HR, Belitsos PC, et al. Cryptosporidiosis in patients with AIDS: correlates of disease and survival. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 1998;27(3):536-42.